Capability details

TransGenRx has developed technology that significantly reduces the cost of producing protein-based drugs by using a high expressing avian cell line combined with their patented vector system. Patented and patent pending processes allow TGRx to develop custom proteins to meet a wide range of specifications. Use the links on the left to learn more about our team as well as our products and services we offer.

This is my company
Link me with this company to list Innovations and Challenges